For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
In the latest session, Arcellx Inc (NASDAQ: ACLX) closed at $51.38 down -2.73% from its previous closing price of $52.82. In other words, the price has decreased by -$2.73 from its previous closing price. On the day, 0.4 million shares were traded. ACLX stock price reached its highest trading level at $51.965 during the session, while it also had its lowest trading level at $49.66.
Ratios:
For a deeper understanding of Arcellx Inc’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 3.89 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 14.71. For the most recent quarter (mrq), Quick Ratio is recorded 6.06 and its Current Ratio is at 6.06. In the meantime, Its Debt-to-Equity ratio is 0.20 whereas as Long-Term Debt/Eq ratio is at 0.10.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Morgan Stanley on March 07, 2024, initiated with a Overweight rating and assigned the stock a target price of $81.
On January 04, 2024, Needham reiterated its Buy rating and also lowered its target price recommendation from $65 to $71.
On December 19, 2023, Scotiabank started tracking the stock assigning a Sector Outperform rating and target price of $66.Scotiabank initiated its Sector Outperform rating on December 19, 2023, with a $66 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Apr 16 ’24 when Ware Olivia C sold 9,402 shares for $55.55 per share. The transaction valued at 522,260 led to the insider holds 0 shares of the business.
Elghandour Rami sold 23,086 shares of ACLX for $1,548,887 on Apr 01 ’24. The insider now owns 69,253 shares after completing the transaction at $67.09 per share. On Mar 26 ’24, another insider, Heery Christopher, who serves as the CHIEF MEDICAL OFFICER of the company, sold 5,450 shares for $69.11 each. As a result, the insider received 376,648 and left with 8,938 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ACLX now has a Market Capitalization of 2814796800 and an Enterprise Value of 2108298240. For the stock, the TTM Price-to-Sale (P/S) ratio is 24.82 while its Price-to-Book (P/B) ratio in mrq is 5.53. Its current Enterprise Value per Revenue stands at 19.111 whereas that against EBITDA is -24.002.
Stock Price History:
Over the past 52 weeks, ACLX has reached a high of $75.10, while it has fallen to a 52-week low of $30.74. The 50-Day Moving Average of the stock is -20.02%, while the 200-Day Moving Average is calculated to be 5.19%.
Shares Statistics:
For the past three months, ACLX has traded an average of 464.19K shares per day and 532390 over the past ten days. A total of 52.28M shares are outstanding, with a floating share count of 39.78M. Insiders hold about 25.35% of the company’s shares, while institutions hold 74.13% stake in the company. Shares short for ACLX as of 1713139200 were 4026326 with a Short Ratio of 8.67, compared to 1710460800 on 3607268. Therefore, it implies a Short% of Shares Outstanding of 4026326 and a Short% of Float of 8.67.
